Deutsche Bank Ag\ Xenon Pharmaceuticals Inc. Transaction History

Deutsche Bank Ag\

$245 Billion
Q1 2025

A detailed history of Deutsche Bank Ag\ transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 53,711 shares of XENE stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,711

Previous 53,711 -0.0%

Holding current value

$1.74 Million

Previous $2.11 Million 14.39%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $543,750 - $656,250	15,000 Added 38.75%	53,711 $2.09 Million
Q1 2024 Jun 02, 2025	SELL	$42.66 - $50.04 $639,900 - $750,600	-15,000 Reduced 27.93%	38,711 $1.67 Million
Q1 2024 May 15, 2024	BUY	$42.66 - $50.04 $1.54 Million - $1.81 Million	36,216 Added 1451.54%	38,711 $1.67 Million
Q3 2023 Nov 09, 2023	SELL	$34.16 - $39.73 $18,412 - $21,414	-539 Reduced 17.77%	2,495 $85,000
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $18,778 - $23,468	539 Added 21.6%	3,034 $116,000
Q4 2022 Feb 13, 2023	BUY	$33.06 - $39.43 $82,484 - $98,377	2,495 New	2,495 $98,000
Q4 2021 Feb 11, 2022	SELL	$15.6 - $35.4 $124,597 - $282,739	-7,987 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$14.86 - $19.45 $117,899 - $154,316	7,934 Added 14969.81%	7,987 $122,000
Q2 2021 Aug 11, 2021	SELL	$16.81 - $20.0 $588 - $700	-35 Reduced 39.77%	53 $1,000
Q1 2021 May 13, 2021	SELL	$13.65 - $21.31 $415,396 - $648,505	-30,432 Reduced 99.71%	88 $1,000
Q4 2020 Feb 16, 2021	BUY	$9.49 - $16.04 $483 - $818	51 Added 0.17%	30,520 $470,000
Q2 2020 Aug 13, 2020	SELL	$10.21 - $14.9 $659,678 - $962,703	-64,611 Reduced 67.95%	30,469 $382,000
Q1 2020 May 14, 2020	BUY	$8.08 - $17.57 $742,923 - $1.62 Million	91,946 Added 2933.82%	95,080 $1.08 Million
Q4 2019 Feb 14, 2020	BUY	$8.11 - $14.65 $25,416 - $45,913	3,134 New	3,134 $41,000
Q3 2019 Nov 14, 2019	SELL	$8.74 - $10.51 $17,890 - $21,513	-2,047 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$8.51 - $10.75 $14,628 - $18,479	-1,719 Reduced 45.65%	2,047 $19,000
Q1 2019 May 15, 2019	SELL	$6.39 - $10.42 $443,683 - $723,502	-69,434 Reduced 94.86%	3,766 $37,000
Q4 2018 Feb 14, 2019	BUY	$5.61 - $12.62 $116,558 - $262,205	20,777 Added 39.63%	73,200 $461,000
Q3 2018 Nov 14, 2018	SELL	$9.0 - $14.9 $619,200 - $1.03 Million	-68,800 Reduced 56.75%	52,423 $691,000
Q2 2018 Aug 14, 2018	BUY	$4.8 - $9.2 $581,870 - $1.12 Million	121,223 New	121,223 $1.12 Million
Q1 2018 May 15, 2018	SELL	$2.7 - $4.9 $23,541 - $42,723	-8,719 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$2.2 - $3.25 $221,848 - $327,730	-100,840 Reduced 92.04%	8,719 $24,000
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.25 $268,419 - $356,066	109,559	109,559 $323,000

Others Institutions Holding XENE

# of Institutions

219

Shares Held

69.9M

Call Options Held

444K

Put Options Held

207K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.02B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account